Skip to main content
. Author manuscript; available in PMC: 2022 Jul 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Sep 1;85(1):106–112. doi: 10.1097/QAI.0000000000002410

Table 4:

Results from multivariable regression models to investigate independent associations of HIV and extent of pain with each self-reported sleep parameter and abnormal ODI: Model 1 – main effects only; Model 2 – including additional adjustment for age, gender, ethnicity, HIV exposure group and educational attainment; Model 3 – including additional adjustment for substance use, pain relief and sleep medication.

Sleep parameter Model 1 Model 2 Model 3

Parameter Estimate (SE) p-value Estimate (SE) p-value Estimate (SD) p-value

ISI (continuous) HIV 2.29 (0.66) 0.0006 2.42 (0.74) 0.001 2.12 (0.73) 0.004
Non-widespread pain 2.45 (0.64) 0.0001 2.44 (0.64) 0.0002 2.29 (0.64) 0.0004
Widespread pain 5.29 (0.84) 0.0001 5.35 (0.87) 0.0001 4.37 (0.90) 0.0001
PROMIS-SD T-score HIV 2.76 (0.96) 0.004 3.75 (1.06) 0.0005 3.47 (1.07) 0.001
Non-widespread pain 3.14 (0.92) 0.0007 3.08 (0.92) 0.0009 2.85 (0.92) 0.002
Widespread pain 5.87 (1.21) 0.0001 5.53 (1.25) 0.0001 4.55 (1.30) 0.0005
PROMIS-SRI T-score HIV 4.66 (0.96) 0.0001 4.58 (1.07) 0.0001 4.31 (1.09) 0.0001
Non-widespread pain 3.94 (0.92) 0.0001 3.96 (0.93) 0.0001 3.83 (0.94) 0.0001
Widespread pain 8.68 (1.21) 0.0001 8.84 (1.25) 0.0001 8.10 (1.32) 0.0001

OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value

RLS HIV 1.01 (0.53, 1.94) 0.98 1.26 (0.61, 2.61) 0.54 1.29 (0.62, 2.71) 0.50
Non-widespread pain 1.94 (0.99, 3.80) 0.05 1.84 (0.93, 3.64) 0.08 1.81 (0.91, 3.61) 0.09
Widespread pain 2.70 (1.23, 5.94) 0.01 2.34 (1.03, 5.30) 0.04 2.28 (0.96, 5.40) 0.06
Insomnia HIV 3.58 (1.57, 8.17) 0.002 3.50 (1.43, 8.55) 0.006 3.25 (1.31, 8.06) 0.01
Non-widespread pain 2.17 (1.11, 4.23) 0.02 2.16 (1.10, 4.25) 0.03 2.04 (1.03, 4.05) 0.04
Widespread pain 4.60 (2.18, 9.68) 0.0001 5.03 (2.31, 10.97) 0.0001 3.68 (1.62, 8.36) 0.002